Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring brain activity and oxygen levels in ARDS patients in the ICU

Official title: Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis

Run by University of Manitoba · NCT05847634 · Data updated 2026-11-12

This study is testing if new non-invasive methods can help doctors find the right level of sedation for patients with acute respiratory distress syndrome in the ICU by monitoring their brain activity and oxygen levels.

More ARDS, Human trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Manitoba
Academic / other
Locations1 site (Winnipeg, Manitoba)
StatusRecruiting
StartedNovember 25, 2024
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedDecember 6, 2024
Trial IDNCT05847634 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients admitted to the ICU with confirmed ARDS requiring deep sedation and/or neuromuscular blockade.

Probably not a fit

Patients who have been in the ICU for more than 24 hours or are deemed to have imminent death will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the feasibility of using non-invasive monitoring techniques, specifically processed electroencephalography (EEG) and near-infrared spectroscopy (NIRS), to assess the optimal depth of sedation in patients with acute respiratory distress syndrome (ARDS) in the intensive care unit (ICU). The research aims to determine how these monitoring methods can help minimize the correlation between brain oxygenation and sedation levels. Data collected will include demographic information, medical history, and sedation dosages, allowing for a comprehensive analysis of sedation effects on cerebrovascular reactivity in ARDS patients.

Why it matters

Potential benefit: If successful, this study could lead to improved sedation management in ARDS patients, enhancing their recovery and outcomes.

How similar studies have gone: While this approach is novel in the context of ARDS, similar monitoring techniques have shown promise in other critical care settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient admitted to the ICU
* ARDS confirmed according to the Berlin Definition
* Invasive mechanical ventilation
* Deep sedation and/or neuromuscular blockade required for ARDS treatment at the discretion of the treating medical team
* Application of monitoring devices feasible

Exclusion Criteria:

* More than 24 hours elapsed since ICU admission
* Death is deemed imminent and inevitable during the next 24 hours
* Known allergy to a textile component of the device
* Consent declined from patient or authorized third party
* The treating clinician believes that participation in the study would not be in the best interest of the patient

Where it's running

  • Health Sciences Centre Winnipeg
    Winnipeg, Manitoba, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.